Replies to post #17573 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

I have a suspicion that both Momenta and Mylan will get approval around the same timeframe. With that said the question is if Sandoz/Momenta/Pfizer can be price competitive with Teva or Mylan/Natco.

If Enoxaparin is any guide it doesn't bode well.

[DewDiligence]

"Target action" dates for ANDAs are not the same as GDUFA dates—i.e. they don't mean much in practice.